Literature DB >> 21538104

Towards new horizons in brain PET.

Marco Pagani.   

Abstract

Mesh：

Substances：

Year:  2011        PMID： 21538104     DOI： 10.1007/s00259-011-1813-1

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  24 in total

1.  Copper-62-ATSM: a new hypoxia imaging agent with high membrane permeability and low redox potential.

Authors:  Y Fujibayashi; H Taniuchi; Y Yonekura; H Ohtani; J Konishi; A Yokoyama
Journal:  J Nucl Med       Date:  1997-07       Impact factor: 10.057

2.  Copper-64-diacetyl-bis (N4-methylthiosemicarbazone) accumulates in rich regions of CD133+ highly tumorigenic cells in mouse colon carcinoma.

Authors:  Yukie Yoshii; Takako Furukawa; Yasushi Kiyono; Ryo Watanabe; Atsuo Waki; Tetsuya Mori; Hiroshi Yoshii; Myungmi Oh; Tatsuya Asai; Hidehiko Okazawa; Michael J Welch; Yasuhisa Fujibayashi
Journal:  Nucl Med Biol       Date:  2010-02-10       Impact factor: 2.408

3.  Mitochondria-selective reduction of 62Cu-pyruvaldehyde bis(N4-methylthiosemicarbazone) (62Cu-PTSM) in the murine brain; a novel radiopharmaceutical for brain positron emission tomography (PET) imaging.

Authors:  Y Fujibayashi; K Wada; H Taniuchi; Y Yonekura; J Konishi; A Yokoyama
Journal:  Biol Pharm Bull       Date:  1993-02       Impact factor: 2.233

4.  The zinc-62/copper-62 generator: a convenient source of copper-62 for radiopharmaceuticals.

Authors:  G D Robinson; F W Zielinski; A W Lee
Journal:  Int J Appl Radiat Isot       Date:  1980-02

5.  Tumor uptake of copper-diacetyl-bis(N(4)-methylthiosemicarbazone): effect of changes in tissue oxygenation.

Authors:  J S Lewis; T L Sharp; R Laforest; Y Fujibayashi; M J Welch
Journal:  J Nucl Med       Date:  2001-04       Impact factor: 10.057

6.  Cell line-dependent differences in uptake and retention of the hypoxia-selective nuclear imaging agent Cu-ATSM.

Authors:  Paul Burgman; Joseph A O'Donoghue; Jason S Lewis; Michael J Welch; John L Humm; C Clifton Ling
Journal:  Nucl Med Biol       Date:  2005-08       Impact factor: 2.408

Review 7.  Assessing tumor hypoxia by positron emission tomography with Cu-ATSM.

Authors:  J P Holland; J S Lewis; F Dehdashti
Journal:  Q J Nucl Med Mol Imaging       Date:  2009-04       Impact factor: 2.346

Review 8.  Molecular imaging of hypoxia with radiolabelled agents.

Authors:  Gilles Mees; Rudi Dierckx; Christel Vangestel; Christophe Van de Wiele
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-06-30       Impact factor: 9.236

9.  Pathophysiologic correlation between 62Cu-ATSM and 18F-FDG in lung cancer.

Authors:  Talakad Goolaiah Lohith; Takashi Kudo; Yoshiki Demura; Yukihiro Umeda; Yasushi Kiyono; Yasuhisa Fujibayashi; Hidehiko Okazawa
Journal:  J Nucl Med       Date:  2009-11-12       Impact factor: 10.057

10.  PET imaging of redox and energy states in stroke-like episodes of MELAS.

Authors:  Masamichi Ikawa; Hidehiko Okazawa; Kenichiro Arakawa; Takashi Kudo; Hirohiko Kimura; Yasuhisa Fujibayashi; Masaru Kuriyama; Makoto Yoneda
Journal:  Mitochondrion       Date:  2009-01-30       Impact factor: 4.160
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.